Article Information
History
- March 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kirsten E. Wiens1,
- Pinyi Nyimol Mawien2,
- John Rumunu2,
- Damien Slater3,
- Forrest K. Jones1,
- Serina Moheed3,
- Andrea Caflish4,
- Bior K. Bior2,
- Iboyi Amanya Jacob2,
- Richard Lino Loro Lako2,
- Argata Guracha Guyo5,
- Olushayo Oluseun Olu5,
- Sylvester Maleghemi5,
- Andrew Baguma5,6,
- Juma John Hassen5,
- Sheila K. Baya5,
- Lul Deng2,
- Justin Lessler1,
- Maya N. Demby1,
- Vanessa Sanchez3,
- Rachel Mills3,
- Clare Fraser3,
- Richelle C. Charles3,7,*,
- Jason B. Harris3,8,*,
- Andrew S. Azman1,9,10,#,† and
- Joseph F. Wamala5,#
- 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 2Republic of South Sudan Ministry of Health, Juba, South Sudan
- 3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
- 4Displacement Tracking Matrix, International Organization for Migration, Juba, South Sudan
- 5World Health Organization, Juba, South Sudan
- 6Kabale University School of Medicine, Department of Microbiology and Immunology
- 7Department of Medicine, Harvard Medical School, Boston, MA, USA
- 8Department of Pediatrics, Harvard Medical School, Boston, MA, USA
- 9Médecins Sans Frontières, Geneva, Switzerland
- 10Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- ↵†Corresponding author, Andrew S. Azman, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6003, Baltimore, Maryland 21205, azman{at}jhu.edu
Posted March 12, 2021.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
